M&M 2021 virtual meeting
At the M&M meeting, leadXpro CEO Michael Hennig will present «Advances in Cryo-EM structure-based methods in membrane protein drug discovery», highlighting recent work on TRPV4, LPTDE and a potassium channel.
news
Latest developments, partnerships and scientific breakthroughs
CryoEM Structure of Lipopolysaccharide Transporter LptDE Opens the Door to Antibiotics Design
Together with the Basel Biozentrum and the Institute of Medical Microbiology in Zurich, leadXpro solved the structure of the bacterial transporter LptDE to provide structural basis for the design of novel antibiotics.
Meet leadXpro CEO Michael Hennig at the Symeres Webinar
leadXpro CEO Michael Hennig showcases examples of successful structure based drug discovery for challenging membrane targets
Join us at the Creoptix waveRAPID launch event
leadXpro supports Creoptix at the launch event for the new waveRAPID kinetics analyzer
leadXpro celebrates its 5th anniversary
On December 2, 2020, leadXpro proudly celebrates its fifth anniversary and looks back on many successful projects with challenging membrane targets.
Strategic Alliance with Axxam and MercachemSyncom
Axxam, leadXpro and MercachemSyncom Form a Strategic Alliance for Structure-based Drug Discovery Services that will allow them to offer world-class integrated structure-guided drug discovery services for membrane protein targets.
leadXpro produces protein for COVID-19 research campaign
leadXpro AG announces its involvement in a multiparty research collaboration by delivering SARS-CoV-2 M-glycoprotein, a promising therapeutic target against Covid-19.
leadXpro, first tenant of Park InnovAARE’s innovation campus
One month after the groundbreaking ceremony of Park Innovaare’s new Innovation Campus, leadXpro is the first company to sign a tenancy agreement.
leadXpro and Lundbeck partner for membrane protein structure research
Lundbeck partners with leadXpro to discover drugs for membrane protein targets by high-resolution X-ray and cryo-Electron Microscopy
leadXpro and Astex enter partnership on membrane protein structure research
Astex Pharmaceuticals partners with leadXpro to facilitate structure-based drug discovery for membrane protein targets by cryo-Electron Microscopy